TANAKA CAPITAL MANAGEMENT INC

Q3 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    45

  • Value ($000)

    $56

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0000816788
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
HTD
HTD

Corcept Therapeutics

COM
$9.24 K
17 %

111,209

UAMY
UAMY

United States Antimony

COM
$5.13 K
9 %

827,035

NVDA
NVDA

Nvidia

COM
$4.64 K
8 %

24,879

NXE
NXE

NexGen Energy

COM
$3.96 K
7 %

442,625

AAPL
AAPL

Apple Computing

COM
$3.30 K
6 %

12,972

NUVB
NUVB

Nuvation Bio Inc.

COM
$2.54 K
5 %

685,105

IJR
IJR

Intellia Therapeutics

COM
$2.49 K
5 %

144,225

SYM
SYM

Symbotic

COM
$2.34 K
4 %

43,454

AFL
AFL

AFLAC Inc.

COM
$2.27 K
4 %

20,369

CPRX
CPRX

Catalyst Pharmaceuticals

COM
$2.25 K
4 %

114,418

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 45